Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
424
Views
4
CrossRef citations to date
0
Altmetric
Articles

Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis

Mark Lebwohla Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Ahmed M. Solimanb AbbVie Inc, North Chicago, IL, USAView further author information
,
Hongbo Yangc Analysis Group, Inc, Boston, MA, USAView further author information
,
Jessie Wangc Analysis Group, Inc, Boston, MA, USAView further author information
,
Jonathan Freimarkc Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
View further author information
&
Lluís Puigd Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0001-6083-0952View further author information
ORCID Icon
Pages 2094-2101 | Received 01 Apr 2021, Accepted 12 Apr 2021, Published online: 16 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tamara W. van Hal, Juul M. P. A. van den Reek, Mark H. Wenink, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Annet Oostveen, Bas Peters, Milan Tjioe, Else N. Kop, John E. M. Körver, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Maartje A. M. Berends, Wendelien R. Veldkamp, Martijn B. A. van Doorn, Johannes M. Mommers, Robert-Jan Lindhout, Astrid L. A. Kuijpers, Paula P. van Lümig, C. (Els) J. de Jonge, Ron A. Tupker, Judith Hendricksen, Romy R. Keijsers, Frank H. J. van den Hoogen, Johanna E. Vriezekolk & Elke M. G. J. de Jong. (2024) Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry. Journal of Dermatological Treatment 35:1.
Read now
Pingping Yao, Yuying Jia, Xuewei Kan, Jiaqi Chen, Jinliang Xu, Huichao Xu, Shuyang Shao, Bing Ni & Jun Tang. (2023) Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification. International Journal of General Medicine 16, pages 6051-6064.
Read now
Tamara Gracia-Cazaña, Laura Bernal-Masferrer, Ana María Morales-Callaghan, Manuel Almenara-Blasco & Yolanda Gilaberte. (2023) Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing. Clinical, Cosmetic and Investigational Dermatology 16, pages 221-229.
Read now

Articles from other publishers (1)

Paolo Gisondi, Davide Geat, Martina Maurelli, Luca Degli Esposti, Francesco Bellinato & Giampiero Girolomoni. (2022) Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease. Vaccines 10:5, pages 646.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.